1,343
Views
8
CrossRef citations to date
0
Altmetric
Pharmacological Aspects

Minding the brain: the role of pharmacotherapy in substance-use disorder treatment

Preocupación por el cerebro: el papel de la farmacoterapia en el tratamiento del trastorno por uso de sustancias

Le rôle de la pharmacothérapie dans Ie traitement des troubles liés à l'utilisation de substances

&

REFERENCES

  • AristotleNicomachean Ethics, 2nd ed. New York, NY: Hackett Publishing Co.1999
  • Jill JonnesHep-Cats, Narcs and Pipe Dreams. Baltimore, MD: John Hopkins University Press;1999
  • LeshnerA.Addiction is a brain disease, and it matters.Science.1997278533545479311924
  • SatelS.LilienfeldSO.Addiction and the brain-disease fallacy.Front Psychiatry.2014414124624096
  • Lopez-QuinteroC.Pérez de los CobosJ.HasinDS.et alProbability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).Drug Alcohol Depend.20111151-212013021145178
  • GableRS.The toxicity of recreational drugs.Am Sci.2006943206
  • StaffordK.GomesAB.ShenJ.YoburnCB.μ-Opioid receptor down-regulation contributes to opioid tolerance in vivo.Pharmacol Biochem Behav.2001691-223323711420091
  • GuptaS.KulharaP.Cellular and molecular mechanisms of drug dependence: an overview and update.Indian J Psychiatry.2007492859020711388
  • KalivasPW.O'BrienC.Drug addiction as a pathology of staged neuroplasticity.Neuropsychopharmacology.200833116618017805308
  • KalivasPW.The glutamate homeostasis hypothesis of addiction.Nat Rev Neurosci.200910856157219571793
  • VolkowND.MoralesM.The Brain on drugs: from reward to addiction.Cell.2015162471227526276628
  • GoldsteinRZ.VolkowND.Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex.Am J Psychiatry.2002159101642165212359667
  • StangerC.BudneyAJ.BickelWK.A developmental perspective on neuroeconomic mechanisms of contingency management.Psychol Addict Behav.201327240341522663343
  • KoberH.KrossEF.MischelW.HartCL.OchsnerKN.Regulation of craving by cognitive strategies in cigarette smokers.Drug Alcohol Depend.20101061525519748191
  • RiesR.et alPrinciples of Addiction Medicine, 4th ed. New York, NY: Lippincott Williams & Wilkins;2010
  • LongD.LongB.KoyfmanA.The emergency medicine management of severe alcohol withdrawal.Am J Emerg Med.20173571005101128188055
  • WadgaveU.NageshL.Nicotine replacement therapy: an overview.Int J Health Sci (Qassim).201610342543527610066
  • HaneyM.CooperZD.BediG.VosburgSK.ComerSD.FoltinRW.Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse.Neuropsychopharmacology.20133881557156523443718
  • HaneyM.HartCL.VosburgSK.ComerSD.ReedSC.FoltinRW.Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse.Psychopharmacology (Berl).2008197115716818161012
  • LingW.WessonDR.CharuvastraC.KlettCJ.A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence.Arch Gen Psychiatry.19965354014078624183
  • AyangaD.ShorterD.KostenTR.Update of pharmacotherapy for treatment of opioid use disorder.Expert Opin Pharmacother.201617(17)172307231827734745
  • BalterRE.CooperZD.HaneyM.Novel pharmacologic approaches to treating cannabis use disorder.Curr Addict Rep.20141213714324955304
  • GarrisonKA.PotenzaMN.Neuroimaging and biomarkers in addiction treatment.Curr Psychiatry Rep.2014161251325308385
  • HserYl.SaxonAJ.HuangD.et alTreatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial.Addiction.20141091798723961726
  • FudalaPJ.BridgeTB.HerbertS.et alBuprenorphine/Naloxone Collaborative Study Group. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone.New Engl J Med.20033491094995812954743
  • WalshSL.PrestonKL.StitzerML.ConeEJ.BigelowGE.Clinical pharmacology of buprenorphine: ceiling effects at high doses.Clin Pharmacol Ther.19945555695808181201
  • CahillK.Lindson-HawleyN.ThomasKH.FanshaweTR.LancasterT.Nicotine receptor partial agonists for smoking cessation.Cochrane Database Syst Rev.2016 5CD00610327158893
  • StoopsWW.RushCR.Agonist replacement for stimulant dependence: a review of clinical research.Curr Pharm Des.201319407026703523574440
  • HartCL.HaneyM.VosburgSK.RubinE.FoltinRW.Smoked cocaine self-administration is decreased by modafinil.Neuropsychopharmacology200833476176817568397
  • MooneyME.HerinDV.SchmitzJM.MoukaddamN.GreenCE.GrabowskiJ.Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial.Drug Alcohol Depend.20091011-2344119058926
  • LevinFR.MarianiJJ.BrooksDJ.PavlicovaM.ChengW.NunesEV.Dronabinol for the treatment of cannabis dependence.Drug Alcohol Depend.20111161-314215021310551
  • HughesJR.SteadLF.Hartmann-BoyceJ.CahillK.LancasterT.Antidepressants for smoking cessation.Cochrane Database Syst Rev.2014 1CD000031. doi:10.1002/14651858.CD000031.pub424402784
  • KampmanKM.The search for medications to treat cocaine dependence.Addict Sci Clin Pract.200842283518497715
  • JohnsonBA.Ait-DaoudN.WangXQ.et alTopiramate for the treatment of cocaine addiction.JAMA Psychiatry.201370121338134624132249
  • JohnsonBA.RosenthalN.CapeceJA.et alTopiramate for Alcoholism Advisory Board; Topiramate for Alcoholism Study Group. Topiramate for treating alcohol addiction.JAMA.2007298141641165117925516
  • HiguchiS.Japanese AcamprosateStudy Group.Efficacy of acamprosate for the treatment of alcohol dependence long after recovery from withdrawal syndrome: a randomized, double-blind, placebo-controlled study conducted in Japan (Sunrise Study).J Clin Psychiatry.201576218118825742205
  • MasonBJ.QuelloS.GoodellV.ShadanF.KyleM.BegovicA.Gabapentin treatment for alcohol dependence.JAMA Intern Med.20141741707724190578
  • MasonBJ.CreanR.GoodellV.et alA proof-of-concept randomized controlled study of gabapentin: effects on use, withdrawal and executive function deficits in cannabis dependent adults.Neuropsychopharmacology.20123771689169822373942
  • MyersKM.CarlezonWA Jr.D-cycloserine effects on extinction of conditioned responses to drug-related cues.Biol Psychiatry.2012711194795522579305
  • Santa AnaEJ.RounsavilleBJ.FrankforterTL.et alD-Cycloserine attenuates reactivity to smoking cues in nicotine dependent smokers: a pilot investigation.Drug Alcohol Depend.2009104322022719592176
  • PopikP.WrobelM.RyglaR.BisagaA.BespakovAY.Effect of memantine, an NMDA receptor antagonist, on place preference conditioned with drug and nondrug reinforces in mice.Behav Pharmacol.200314323724412799526
  • GarbuttJC.Kampov-PolevoyAB.Kalka-JuhlLS.GallopRJ.Association of the Sweet-Liking Phenotype and Craving for Alcohol With the Response to Naltrexone Treatment in Alcohol Dependence: a randomized clinical trial.JAMA Psychiatry.201673101056106327627782
  • KrupitskyE.NunesEV.LingW.llleperumaA.GastfriendDR.SilvermanBL.Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial.Lancet.2011377977615061513021529928
  • ladarolaND.NiciuMJ.RichardsEM.et alKetamine and other Nmethyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review.Ther Adv Chronic Dis.2015639711425954495
  • DakwarE.LevinF.FoltinRW.NunesEV.HartCL.The effects of subanesthetic ketamine infusions on motivation to quit and cue-induced craving in cocaine-dependent research volunteers.Biol Psychiatry.2014761404624035344
  • DakwarE.HartCL.LevinFR.NunesEV.FoltinRW.Cocaine self-administration disrupted by the Ai-methyl-D-aspartate receptor antagonist ketamine: a randomized, cross-over trial.Mol Psychiatry.2016221768127090301
  • DuttaA.McKieS.DeakinJF.Ketamine and other potential glutamate antidepressants.Psychiatry Res.20152251-211325467702
  • ScheideggerM.WalterM.LehmannM.et alKetamine decreases resting state functional network connectivity in healthy subjects: implications for antidepressant drug action.PloS One.201279e4479923049758
  • BerglindWJ.SeeRE.FuchsRA.et alA BDNF infusion into the medial prefrontal cortex suppresses cocaine seeking in rats.Eur J Neurosci.200726375776617651427
  • van de GiessenE.WeinsteinJJ.CassidyCM.et alDeficits in striatal dopamine release in cannabis dependence.Mol Psychiatry.2017221687527001613
  • MartinezD.CarpenterKM.LiuF.SlifsteinM.et alImaging dopamine transmission in cocaine dependence: response to treatment linked to neurochemistry.Am J Psychiatry.2011168663464121406463
  • TorrensM.FonsecaF.MateuG.FarréM.Efficacy of antidepressants in substance use disorders with and without comorbid depression: a systematic review and meta-analysis.Drug Alcohol Depend.200578112215769553
  • MoellerFG.SchmitzJM.SteinbergJL.et alCitalopram combined with behavioral therapy reduces cocaine use: a double-blind, placebocontrolled trial.Am J Drug Alcohol Abuse.200733336737817613964
  • MarkouA.KoobGF.Postcocaine anhedonia: an animal model of cocaine withdrawal.Neuropsychopharmacology.19914117262003866
  • Garcia-GarciaI.HorstmannA.JuradoMA.et alReward processing in obesity, substance addiction and non-substance addiction.Obes Rev.2014151185386925263466
  • GrayKM.CarpenterMJ.BakerNL.et alA double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents.Am J Psychiatry.2012169880581222706327
  • LaRoweSD.KalivasPW.NicholasJS.RandallPK.MarkikianPN.MalcolmRJ.A double-blind placebo-controlled trial of W-acetylcysteine in the treatment of cocaine dependence.Am J Addict.201322544345223952889
  • BelujonP.JakobowskiNL.DollishHK.GraceAA.Withdrawal from acute amphetamine induces an amygdala-driven attenuation of dopamine neuron activity: reversal by ketamine.Neuropsychopharmacology201641261962726129677
  • DakwarE.AnerellaC.HartCL.LevinFR.MathewSJ.NunesEV.Therapeutic infusions of ketamine: do the psychoactive effects matter?Drug Alcohol Depend.201413615315724480515
  • JamesW.The Varieties of Religious Experience: A Study in Human Nature. Oxford, UK: Oxford World's Classics1907
  • FerriMM.AmatoL.DavoliM.Alcoholics Anonymous and other 12step programmes for alcohol dependence.Cochrane Database Syst Rev.2006 3CD00503216856072
  • McLellanAT.ArndtIO.MetzgerDS.WoodyGE.O'BrienCP.The effects of psychosocial services in substance abuse treatment.JAMA.199326915195319498385230